Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Hyperion
Therapeutics, Inc. ("Hyperion” or "the Company") (Nasdaq:HPTX) for
possible breaches of fiduciary duty and other violations of state law in
connection with the sale of the Company to Horizon Pharma plc.
(“Horizon”).
Click here to learn more about the investigation http://brodsky-smith.com/911-hptx-hyperion-therapeutics-inc.html,
or call: 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Hyperion shareholders will receive
only $46.00 in cash for each share of Hyperion stock they own. The
investigation concerns whether the Board of Hyperion breached their
fiduciary duties to stockholders by failing to adequately shop the
Company before agreeing to enter into this transaction, and whether
Horizon is underpaying for Hyperion. The transaction may undervalue
Hyperion which manufactures the drug Ravicti, a treatment for Urea Cycle
disorder. The FDA approved Ravicti in 2013 and the drug has annual sales
of $105 million. However, Hyperion has estimated that Urea Cycle
disorder is substantially under diagnosed providing ample room for
growth. As a result, an analyst has set a $52.00 per share price target
for Hyperion stock and following the announcement Horizon stock was up
18%.
If you own shares of Hyperion stock and wish to discuss the legal
ramifications of the investigation, or have any questions, you may
e-mail or call the law office of Brodsky & Smith, LLC who will, without
obligation or cost to you, attempt to answer your questions. You may
contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky &
Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by
visiting http://brodsky-smith.com/911-hptx-hyperion-therapeutics-inc.html,
or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise
representing shareholders throughout the nation in securities and class
action lawsuits. The attorneys at Brodsky & Smith have been appointed by
numerous courts throughout the country to serve as lead counsel in class
actions and have successfully recovered millions of dollars for our
clients and shareholders. Attorney advertising. Prior results do not
guarantee a similar outcome.
Copyright Business Wire 2015